Thermo Fisher Scientific Inc (TMO) Shares Sold by Aureus Asset Management LLC

Aureus Asset Management LLC reduced its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 19.5% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 86,422 shares of the medical research company’s stock after selling 20,920 shares during the quarter. Thermo Fisher Scientific comprises 2.5% of Aureus Asset Management LLC’s holdings, making the stock its 12th largest holding. Aureus Asset Management LLC’s holdings in Thermo Fisher Scientific were worth $15,078,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. Proficio Capital Partners LLC increased its holdings in shares of Thermo Fisher Scientific by 71.5% during the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock valued at $105,000 after acquiring an additional 253 shares in the last quarter. Chicago Partners Investment Group LLC bought a new stake in shares of Thermo Fisher Scientific during the second quarter valued at approximately $108,000. Cribstone Capital Management LLC increased its holdings in shares of Thermo Fisher Scientific by 8.7% during the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock valued at $109,000 after acquiring an additional 50 shares in the last quarter. Sharkey Howes & Javer increased its holdings in shares of Thermo Fisher Scientific by 1.0% during the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock valued at $113,000 after acquiring an additional 7 shares in the last quarter. Finally, Shine Investment Advisory Services Inc. bought a new stake in shares of Thermo Fisher Scientific during the second quarter valued at approximately $113,000. Institutional investors and hedge funds own 83.61% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Thermo Fisher Scientific Inc (TMO) Shares Sold by Aureus Asset Management LLC” was reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.com-unik.info/2017/11/01/thermo-fisher-scientific-inc-tmo-shares-sold-by-aureus-asset-management-llc.html.

Shares of Thermo Fisher Scientific Inc (NYSE TMO) opened at 193.83 on Wednesday. The company’s 50-day moving average price is $191.75 and its 200 day moving average price is $178.88. The company has a market cap of $75.62 billion, a P/E ratio of 33.77 and a beta of 1.05. Thermo Fisher Scientific Inc has a one year low of $139.07 and a one year high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The company had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same quarter last year, the company earned $2.03 EPS. The firm’s revenue for the quarter was up 13.9% on a year-over-year basis. On average, equities research analysts anticipate that Thermo Fisher Scientific Inc will post $9.36 earnings per share for the current year.

Several research firms have recently commented on TMO. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $215.00 price objective for the company in a report on Tuesday. Deutsche Bank AG set a $226.00 price objective on Thermo Fisher Scientific and gave the company a “buy” rating in a report on Thursday, October 26th. Leerink Swann restated a “buy” rating on shares of Thermo Fisher Scientific in a report on Monday. Jefferies Group LLC restated a “hold” rating and set a $195.00 price objective on shares of Thermo Fisher Scientific in a report on Thursday, September 28th. Finally, BidaskClub downgraded Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. One equities research analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $205.71.

In related news, VP Peter E. Hornstra sold 3,894 shares of the firm’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $185.18, for a total transaction of $721,090.92. Following the completion of the transaction, the vice president now owns 19,751 shares of the company’s stock, valued at approximately $3,657,490.18. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Seth H. Hoogasian sold 4,140 shares of the firm’s stock in a transaction that occurred on Monday, August 28th. The shares were sold at an average price of $177.80, for a total value of $736,092.00. Following the transaction, the vice president now directly owns 25,518 shares of the company’s stock, valued at approximately $4,537,100.40. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 22,738 shares of company stock valued at $4,021,512. 0.49% of the stock is owned by corporate insiders.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit